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Abstract
Early HIV diagnosis enables prompt treatment initiation, thereby contributing to decreased 
morbidity, mortality, and transmission. We aimed to describe the association between distance 
from residence to testing sites and HIV disease stage at diagnosis. Using HIV surveillance data, 
we identified all new HIV diagnoses made at publicly-funded testing sites in central North 
Carolina during 2005-2013. Early-stage HIV was defined as acute HIV (antibody-negative test 
with a positive HIV RNA) or recent HIV (normalized optical density <0.8 on the BED assay for 
non-AIDS cases); remaining diagnoses were considered post-early-stage HIV. Street distance 
between residence at diagnosis and 1) the closest testing site and 2) the diagnosis site was 
dichotomized at 5 miles. We fit log-binomial models using generalized estimating equations to 
estimate prevalence ratios (PR) and robust 95% CI for post-early-stage diagnoses by distance. 
Models were adjusted for race/ethnicity and testing period. Most of the 3028 new diagnoses were 
black (N=2144; 70.8%), men who have sex with men (N=1685; 55.7%), and post-early-stage HIV 
diagnoses (N=2010; 66.4%). Overall, 1145 (37.8%) cases traveled <5 miles for a diagnosis. 
Among cases traveling ≥5 miles for a diagnosis, 1273 (67.6%) lived <5 miles from a different site. 
Residing ≥5 miles from a testing site was not associated with post-early-stage HIV (adjusted PR, 
95% CI: 0.98, 0.92-1.04), but traveling ≥5 miles for a diagnosis was associated with higher post-
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early HIV prevalence (1.07, 1.02-1.13). Most of the elevated prevalence observed in cases 
traveling ≥5 miles for a diagnosis occurred among those living <5 miles from a different site (1.09, 
1.03-1.16). Modest increases in post-early-stage HIV diagnosis were apparent among persons 
living near a site, but choosing to travel longer distances to test. Understanding reasons for 
increased travel distances could improve accessibility and acceptability of HIV services and 
increase early diagnosis rates.
Keywords
recent HIV infection; surveillance; HIV testing; geographic distance; barriers to testing; late 
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Introduction
Diagnosis and presentation to care during early stages of HIV contribute to decreased 
disease-related morbidity, mortality and transmission risk (Cohen et al., 2011; Marks, 
Crepaz, Senterfitt, and Janssen (2005); Metsch et al., 2008; “Life expectancy,” 2008). 
However, approximately 25% of newly HIV-diagnosed persons in the United States are 
simultaneously diagnosed with AIDS, representing diagnoses late in the course of disease 
(“HIV Surveillance Supplemental Report”, 2015).
A lack of accessible HIV services and living in rural areas contribute to testing delays 
(Leibowitz & Taylor, 2007; Ohl & Perencevich, 2011). In the American South, many HIV-
infected persons live in rural areas (Whetten & Reif, 2006), and poverty, distrust in the 
medical system and perceived stigma toward HIV-infected persons result in additional 
barriers to HIV services (Konkle-Parker, Erlen, & Dubbert, 2008; Krawczyk, Funkhouser, 
Kilby, & Vermund, 2006). Our primary goals were to determine if HIV diagnosis more than 
approximately 6 months after infection (post-early-stage) was associated with 1) distance 
from residence to the closest testing site, 2) distance from residence to the diagnosis site 
and/or 3) being diagnosed farther away than geographically necessary among those living 
near a testing site.
Methods
We used data reported in the North Carolina (NC) electronic HIV/AIDS reporting system 
(eHARS) between July 2005 and June 2013. Cases were identified as persons newly 
diagnosed with HIV at publicly-funded testing sites who were 1) ≥16 years of age (to protect 
confidentiality of adolescent cases), 2) not living in correctional facilities and 3) residing 
within a 52-county study area in central NC. The 48 excluded counties contained <20% of 
new HIV diagnoses; spatial analyses in areas of very low prevalence are problematic and 
associated with privacy concerns.
For all new diagnoses reported in eHARS, we assigned a disease stage at diagnosis using a 
three-step process. First, we identified all acute HIV infection (AHI) as antibody-negative 
tests with reproducibly positive HIV RNA (Pilcher et al., 2002; Pilcher et al., 2004). Next, 
we identified cases diagnosed with AIDS ≤6 months after an HIV diagnosis. For the 
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remaining cases, the CDC-administered serologic testing algorithm for recent HIV 
seroconversion (STARHS) results were used to distinguish recent (≤ approximately 6 
months) from chronic (> approximately 6 months) infection, based on a normalized optical 
density cut-point of <0.8 on the BED assay (Hall et al., 2008). All non-AHI and non-AIDS 
cases without STARHS testing results were excluded from analysis. We considered AHI and 
recent diagnoses as “early-stage” disease and chronic and AIDS diagnoses as “post-early-
stage” disease.
Residential addresses of new HIV cases were geocoded to an ESRI-supplied NC street 
basemap using ArcGIS (version 10.1, Redlands, CA). Persons with incomplete addresses 
were geocoded to a population-weighted, random point in the provided zip code. Census 
tract at diagnosis was assigned based on this geocoded address. The addresses of 326 
publicly-funded HIV testing sites in NC providing samples to the state lab for processing 
(“Epidemiologic Profile,” 2013; “NC HIV/STD Testing”) were also geocoded. The street 
distance (miles) between each case's residential address and both 1) the diagnosis site and 2) 
the closest publicly-funded testing site was calculated using the ArcGIS Network Analyst 
extension. We dichotomized each distance variable at 5 miles.
We fit log-binomial regression models using generalized estimating equations to estimate 
prevalence ratios (PR) and robust 95% confidence intervals (CI) of post-early-stage 
diagnoses by dichotomized distance (<5 miles versus ≥5 miles) between residence and the 
closest testing site. We repeated this analysis twice, first using distance to diagnosis site as 
the explanatory variable and then using a composite distance measure (closest site and 
diagnosis site <5 miles; diagnosed ≥5 miles, but closest testing site <5 miles; closest site and 
diagnosis site ≥5 miles). The latter analysis evaluated whether the prevalence of post-early 
stage diagnosis was associated with being diagnosed somewhere other than the most 
proximate site among those living <5 miles of a testing site. We accounted for clustering of 
the outcome at the census tract, which served as a proxy for neighborhood-level 
characteristics, with an exchangeable correlation matrix. Models were adjusted for race/
ethnicity and time period based on a directed acyclic graph. Effect measure modification by 
race/ethnicity and sexual risk status was also assessed.
All statistical analyses were conducted in SAS version 9.3 (Cary, NC). This research was 
deemed exempt by the University of North Carolina Institutional Review Board.
Results
Among 4023 persons diagnosed with HIV at publicly-funded testing sites in central NC 
during 2005-2013, we could classify disease stage at diagnosis for 3242 (80.6%) persons. 
We excluded an additional 214 cases without a geocodable address, resulting in a study 
population comprised of 3028 people (1018 early-stage; 2010 post-early-stage). Most were 
black (N=2144; 70.8%) and men who have sex with men (MSM) (N=1685; 55.7%, 
including MSM who also injected drugs). The median age was 29 years (IQR 23-40) [Table 
1].
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Approximately 35% of black and white persons were diagnosed during early-stage disease, 
compared to 21.5% of Hispanics. Early-stage diagnoses had a lower median age (25 versus 
32 years) and were most common from 2011-2013 (38.2%). [Table 1].
All new diagnoses lived within 30 miles and 80% lived <5 miles from a publicly-funded 
testing facility. The median distance traveled for a diagnosis was greater than that to the 
closest site [6.6 (IQR 3.6-12.3) versus 2.1 miles (IQR 1.1-4.1)]. Overall, 1145 (37.8%) cases 
were diagnosed <5 miles from their residence [Table 2]. Of the remaining 1883 cases who 
traveled ≥5 miles for their diagnosis, 1273 (67.6%) lived <5 miles from a different publicly-
funded testing site.
Living ≥5 miles from the closest testing site compared to <5 miles had no association with 
post-early stage diagnosis (adjusted (a)PR=0.97, 95% CI 0.91-1.03). The prevalence of post-
early-stage diagnosis among persons traveling ≥5 miles for a diagnosis was slightly greater 
than those traveling <5 miles (aPR=1.08, 95% CI 1.02-1.14) [Table 2].
The increase in prevalence of post-early-stage diagnoses among cases who traveled ≥5 miles 
for a diagnosis occurred primarily among persons who lived <5 miles from a different 
publicly-funded testing site (aPR=1.09, 95% CI 1.03-1.16). This translated to a six-
percentage-point absolute difference in post-early-stage disease prevalence compared to 
those who tested at sites <5 miles from their residence. Upon further stratification, this 
relationship was statistically significant only among black (aPR=1.13, 95% CI 1.05-1.21) 
and MSM cases (aPR=1.10, 95% CI 1.02-1.20) [Table 2].
Discussion
An increase in post-early-stage HIV diagnosis was apparent among NC residents living near 
a testing site, but testing farther away than geographically necessary. The association 
between testing distance and infection stage was modest, with only small increases in post-
early-stage diagnosis among persons traveling ≥5 miles to test but living <5 miles from 
another facility.
In NC, few new HIV cases tested at the facility closest to them. Among those living <5 
miles from a testing site but diagnosed at a less proximate site, the increased prevalence of 
post-early-stage diagnoses occurred primarily among black and MSM cases, groups 
traditionally HIV-burdened in the South. Limited awareness of available nearby HIV 
services, or perceptions about disease-related stigma, inadequate HIV services, and 
confidentiality may influence people living in the South to seek HIV testing from less 
proximate facilities (Krawczyk et al., 2006; Leibowitz & Taylor, 2007; Reif, Geonnotti, & 
Whetten, 2006; “Southern AIDS Coalition,” 2012).
Distance is an easy-to-derive measure, but may not fully explain geographical accessibility 
to HIV services. The type and efficiency of available transportation systems differ across 
communities (Guagliardo, 2004), impacting the cost and time required to travel from 
location to location. Moreover, decisions about where to access medical services are 
sometimes made based on the location of friends, family or daily activities rather than 
residence (Eberhart, Share, Shpaner, & Brady, 2014).
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Although a substantial proportion of HIV testing in the South is conducted in health 
departments (Sutton, Anthony, Vila, McLellan-Lemal, & Weidle, 2010), approximately 40% 
of diagnoses in NC are made at public sites. Test-seeking patterns, demographics, and 
transmission risk behaviors among people testing at public sites may differ from those 
diagnosed by private providers, possibly limiting the generalizability of our results.
The use of STARHS data to assess recent HIV infection has limitations. The BED assay may 
misclassify late-stage disease (Barnighausen, McWalter, Rosner, Newell, & Welte, 2010). 
We attempted to minimize this phenomenon by identifying and removing AIDS cases prior 
to assessing STARHS results. Furthermore, approximately 20% of HIV diagnoses were 
missing STARHS results and were excluded. These cases were more often older and black 
(data not shown), which may bias our results.
Distance to diagnosis site appears to have a small, yet nontrivial, impact on the prevalence of 
post-early-stage HIV diagnoses in NC. The approximately 120 people diagnosed during 
post-early stages living near a testing site, yet choosing to travel farther to test, did not have 
the opportunity to benefit from early care and treatment. Reasons for traveling farther and 
receiving a diagnosis later in the course of infection are likely varied and may cause delays 
in linking to HIV care and initiating treatment (Sutton et al., 2010). Interventions increasing 
accessibility of HIV services (e.g., providing transportation, reducing stigma) could improve 
infection awareness, disease management and transmission prevention.
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Table 1
Demographics of persons newly-diagnosed with HIV at publicly-funded testing sites in a 52-county region in 
central North Carolina, 2005-2013
Total N=3028 Early Stage Cases N=1018 Post-Early Stage Cases N=2010
Median (IQR) Median IQR Median IQR
Age 29 (23-40) 25 (21-35) 32 (24-42)
N N %* N %*
Stage of Diagnosis
    AHI 156 156 (100.0) -- --
    RHI 904 904 (100.0) -- --
    CHI 1659 -- -- 1659 (100.0)
    AIDS 497 -- -- 497 (100.0)
Gender
    Female 717 57 (33.2) 479 (66.8)
    Male 2311 780 (33.8) 1531 (66.2)
Race
    Black 2144 758 (35.4) 1386 (64.6)
    White NH 472 161 (34.1) 311 (65.9)
    Hispanic 302 65 (21.5) 237 (78.5)
    Other 110 34 (30.9) 76 (69.1)
Risk Group
    MSM 1668 641 (38.4) 1027 (61.6)
    Injection Drug User (IDU) 69 24 (34.8) 45 (65.2)
    MSM/IDU 17 6 (35.3) 11 (64.7)
    Other 444 125 (28.2) 319 (71.8)
Period of Diagnosis
    2005-2007 970 308 (31.8) 662 (68.2)
    2008-2010 1305 422 (32.3) 883 (67.7)
    2011-2013 753 288 (38.2) 465 (61.8)
Testing Site
    HIV Counselling and Testing Agency 2265 771 (34.0) 1494 (66.0)
    STD Clinic 212 79 (37.3) 133 (62.7)
    Outpatient Facility 294 94 (32.0) 200 (68.0)
    Other 257 74 (28.8) 183 (71.2)
Rural/Urban†
    Urban 2812 949 (33.7) 1863 (66.3)




As defined by the Rural Urban Commuting Area Codes (“University of Washington,”)
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